Stopped Subject registration did not proceed as expected; difficult to complete within scheduled time frame; prematurely terminated w/ 21 subjects randomized.
Conditions
Cancer
Constipation
Interventions
DRUG: alvimopan
DRUG: Placebo
DRUG: Alvimopan 0.5 mg/day
DRUG: Alvimopan 1 mg/day
Sponsor
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)